Alzheimer’s heartache for millions as wonder drug rejected by NHS
The medicines watchdog’s decision means the drug will only be available privately. (Image: Getty) Hopes of a an Alzheimer’s treatment revolution have been dashed for millions of people after the medicines watchdog ruled a breakthrough drug was too expensive for use on the NHS. Lecanemab is the world’s first drug proven to slow the disease’s … Read more
